Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04507503
Title Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Taiho Oncology, Inc.
Indications

cholangiocarcinoma

Therapies

Futibatinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST